Latest filing published 28 May 2025 for SenzaGen AB, €5,077.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Paul Yianni across 2 companies, led by SenzaGen AB and Humble Group AB. We count 7 filings; the first trade dates from 10 November 2021 and the latest from 27 May 2025.
Every open-market trade on record is a purchase: 7 purchases worth €75k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 4 purchases and no sales.
A typical purchase (the median) is worth €5,316. Clusters matter here: 2 out of 7 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 28 May 2025, the filings show an open-market purchase worth €5,316 in SenzaGen AB. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration